Viatris and Mapi Pharma to Highlight Latest Results of Multi

/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, and Mapi Pharma today announced that recent data from ongoing studies of GA Depot 40...

Related Keywords

China , Shanghai , India , United States , Hyderabad , Andhra Pradesh , Boston , Massachusetts , Israel , American , Aarone Miller , Abhijit Barve , Mapi Pharma , Fingolimod Gilenya , Apremilast Otezla , Ehud Marom , Viatris Inc , Exhibition Center , Boston Convention , Nasdaq , Prnewswire Viatris Inc , American Academy Of Neurology , Youtube , Linkedin , American Academy , Annual Meeting , Chief Medical Officer , Chief Executive Officer , Placebo Controlled Study , Relapsing Forms , Multiple Sclerosis , Glatiramer Acetate , Administered Once Every Four , Global Healthcare , Finished Dosage Forms ,